The U.S. Food and Drug Administration has delayed its decision on marketing approval for Stealth BioTherapeutics' treatment ...

Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...

The Food and Drug Administration is phasing out the use of petroleum-based synthetic dyes by the end of 2026 - a change that ...

The U.S. Food and Drug Administration will meet its targets for completing reviews of new drugs despite mass firings at the ...

President Trump’s first 100 days has roiled health and science as part of the administration’s plan to reshape the federal ...

Stealth BioTherapeutics had expected the FDA to respond on Tuesday to its marketing application for elamipretide to treat ...

Health officials say the initiative will help fast-track the review of safer alternatives. They say the first two dyes out of ...

The high is quick, but the consequences of this drug are long-term. The inhalant nitrous oxide, commonly known as whippets, ...

U.S. health agencies announced that the food industry will begin "phasing out" eight artificial food dyes in the coming years ...

As pressure grows to get artificial colors out of the U.S. food supply, the shift may well start at Abby Tampow’s laboratory ...

An urgent recall has been issued for a bread brand sold throughout the U.S. that could contain "glass fragments," according ...

Novo Nordisk is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...